Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. 1976

H J Shull, and G R Wilkinson, and R Johnson, and S Schenker

Oxazepam (Serax) is a tranquilizer-sedative of the benzodiazepine group that is predominantly metabolized to a pharmacologically inactive glucuronide and subsequently excreted by way of the kidneys. We administered this drug as a single oral dose to seven patients with acute viral hepatitis, to six with cirrhosis, and to age-matched control subjects. Elimination half-life (T1/2) and the apparent oral plasma clearance for the drug in patients with hepatitis and cirrhosis were comparable to values obtained in age-matched controls (P greater than 0.05). In addition, the apparent volume of distribution of oxazepam, its plasma binding, blood/plasma ratio, and the rate of urinary excretion of oxazepam, predominantly as the glucuronide, were comparable (p greater than 0.05) in the two groups of patients with liver disease and their respective controls. Unlike many other sedatives, oxazepam is eliminated normally in patients with parenchymal liver disease an therefore, on pharmacokinetic grounds, seems to be an excellent sedative for use in such persons.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
August 1979, Clinical pharmacology and therapeutics,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
January 1977, Acta pharmacologica et toxicologica,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
February 1971, Lancet (London, England),
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
May 1975, Clinics in gastroenterology,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
May 1974, Clinics in gastroenterology,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
December 1967, Il Policlinico. Sezione medica,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
January 1989, Vojnosanitetski pregled,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
July 1976, Clinical pharmacology and therapeutics,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
March 1977, Clinical pharmacology and therapeutics,
H J Shull, and G R Wilkinson, and R Johnson, and S Schenker
May 1987, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!